氨酸对便秘占主导地位的刺激性肠综合征的潜在影响
Li Cui1, Shuting Zou1, Jing Liu1
1Jiangsu Province Academy of Traditional Chinese Medicine, 210028 Nanjing, China.
高分子量氨酸 (H-HMW-SH) 通过减少炎症和改善肠道屏障功能,有效治疗便秘占主导地位的刺激性肠综合征 (IBS-C). 这项研究强调了H-HMW-SH作为IBS-C的有希望的治疗剂.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 便秘占主导地位的刺激性肠综合征 (IBS-C) 是由于有效治疗方法有限而造成的重大未满足的医疗需求.
- 氨酸 (SH) 正在研究其在胃肠道疾病中的治疗潜力.
研究的目的:
- 为了评估不同分子量氨酸 (SH) 在IBS-C的老鼠模型中的疗效.
- 阐明作用的潜在机制,包括抗炎作用,肠道屏障恢复和肠道菌群的调节.
主要方法:
- 鼠被诱导使用IBS-C,并用低,中,或高分子量SH (LMW-SH,MMW-SH,HMW-SH) 治疗.
- 通过监测体重,便产量,便水分,内脏过敏和胃肠道过渡率来评估有效性.
- 分析了促炎性细胞因子水平 (IL-1β,IL-18,TNF-α),紧结蛋白表达 (克劳丁-1,奥克卢丁,ZO-1),以及肠道菌群的组成.
主要成果:
- 高分子量SH (H-HMW-SH) 证明了IBS-C症状的最显著改善.
- H-HMW-SH治疗减少了促炎性细胞因子,并增强了紧结蛋白的表达,表明改善了肠道屏障完整性.
- H-HMW-SH恢复了胃肠道和便的各个部分的肠道菌群的平衡.
结论:
- 高分子量氨酸对治疗IBS-C具有显著的治疗潜力.
- 该机制涉及减少肠道炎症,加强肠道屏障,并重新平衡肠道微生物群.
- H-HMW-SH代表了一种有前途的新型治疗策略,用于管理IBS-C.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Irritable Bowel Syndrome III: Medical and Nursing Management
